Breaking News, Promotions & Moves

Ligand Pharmaceuticals Unveils Two New VPs of Investments, Business Development

Peter Renehan, MD, and Lee Brown will both report to SVP Paul Hadden.

Author Image

By: Patrick Lavery

Content Marketing Editor

Ligand Pharmaceuticals, a royalty aggregator with numerous biopharmaceutical companies, has two new Vice Presidents of Investments and Business Development. Peter Renehan, MD, and Lee Brown will both report to Ligand Senior Vice President of Investments and Business Development Paul Hadden. Their responsibilities will include sourcing and transacting royalty financing opportunities. Additionally, Lauren Hay is elevated by Ligand to its senior leadership team as Vice President of Portfolio ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters